Stock listing
LS Exchange:A2P4JE Protara Therapeutics, Inc. Aktie
German listing (LS Exchange) of Protara Therapeutics, Inc. · home listing NASDAQ:TARA
Follow Protara Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:TARA
$2.48 USD -0.04 (-1.6%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TARA
- Day range
- $2.43 – $2.57 USDOct 30, 2026
- Volume
- 580,926 sharesOct 30, 2026
- Market cap
- $146.6M USDAt the close on Oct 30, 2026 · price × 59.10M shares outstanding
- 52-week range
- $2.28 – $7.82 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $2.97M USDMedian day 567,134 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TARA · Home | $2.48 USD | -0.04 (-1.6%) | 580,926 | $2.55 | $2.57 | $2.43 | $2.52 | Close on Oct 30, 2026 |
| Frankfurt:1KPA | €2.036 EUR | -0.124 (-5.7%) | — | €2.036 | €2.036 | €2.036 | €2.16 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:TARA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.48 | -0.04 | -1.6% | $2.55 | $2.57 | $2.43 | 580,926 | |
| $2.52 | +0.03 | +1.2% | $2.52 | $2.625 | $2.50 | 553,341 | |
| $2.49 | +0.02 | +0.8% | $2.45 | $2.515 | $2.365 | 1,207,175 | |
| $2.47 | +0.12 | +5.1% | $2.33 | $2.475 | $2.31 | 1,842,772 | |
| $2.35 | +0.02 | +0.9% | $2.35 | $2.43 | $2.305 | 892,638 | |
| $2.33 | -0.11 | -4.5% | $2.39 | $2.47 | $2.28 | 867,600 | |
| $2.44 | -0.06 | -2.4% | $2.47 | $2.525 | $2.42 | 1,760,900 | |
| $2.50 | -0.06 | -2.3% | $2.57 | $2.61 | $2.49 | 971,200 | |
| $2.56 | +0.23 | +9.9% | $2.34 | $2.575 | $2.33 | 1,500,400 | |
| $2.33 | +0.01 | +0.4% | $2.35 | $2.43 | $2.295 | 1,178,000 | |
| $2.32 | -0.08 | -3.3% | $2.38 | $2.465 | $2.32 | 1,163,300 | |
| $2.40 | -0.08 | -3.2% | $2.51 | $2.558 | $2.375 | 861,700 | |
| $2.48 | -0.14 | -5.3% | $2.60 | $2.659 | $2.47 | 701,400 | |
| $2.62 | -0.15 | -5.4% | $2.77 | $2.83 | $2.615 | 930,200 | |
| $2.77 | +0.015 | +0.5% | $2.75 | $2.79 | $2.705 | 1,080,600 | |
| $2.755 | +0.105 | +4.0% | $2.69 | $2.785 | $2.65 | 1,037,300 | |
| $2.65 | +0.06 | +2.3% | $2.59 | $2.69 | $2.515 | 1,215,500 | |
| $2.59 | +0.035 | +1.4% | $2.54 | $2.67 | $2.51 | 731,300 | |
| $2.555 | -0.075 | -2.9% | $2.63 | $2.70 | $2.53 | 803,500 | |
| $2.63 | -0.07 | -2.6% | $2.71 | $2.72 | $2.565 | 1,397,600 | |
| $2.70 | -0.06 | -2.2% | $2.81 | $2.95 | $2.62 | 1,909,100 | |
| $2.76 | -0.29 | -9.5% | $3.06 | $3.10 | $2.745 | 4,999,000 | |
| $3.05 | -0.16 | -5.0% | $3.23 | $3.30 | $2.98 | 8,824,900 | |
| $3.21 | -0.04 | -1.2% | $3.33 | $3.345 | $3.21 | 391,500 | |
| $3.25 | -0.03 | -0.9% | $3.27 | $3.386 | $3.19 | 431,100 | |
| $3.28 | -0.07 | -2.1% | $3.35 | $3.44 | $3.23 | 552,900 | |
| $3.35 | -0.19 | -5.4% | $3.54 | $3.55 | $3.315 | 661,900 | |
| $3.54 | -0.14 | -3.8% | $3.69 | $3.75 | $3.44 | 882,800 | |
| $3.68 | +0.17 | +4.8% | $3.55 | $3.88 | $3.55 | 2,893,300 | |
| $3.51 | -0.04 | -1.1% | $3.59 | $3.68 | $3.47 | 735,300 | |
| $3.55 | -0.15 | -4.1% | $3.69 | $3.725 | $3.45 | 3,945,700 | |
| $3.70 | +0.08 | +2.2% | $3.65 | $3.76 | $3.62 | 654,000 | |
| $3.62 | -0.13 | -3.5% | $3.78 | $3.87 | $3.615 | 2,060,500 | |
| $3.75 | -0.16 | -4.1% | $3.91 | $3.94 | $3.74 | 899,800 | |
| $3.91 | +0.09 | +2.4% | $3.83 | $4.015 | $3.818 | 735,200 | |
| $3.82 | +0.03 | +0.8% | $3.83 | $3.95 | $3.81 | 532,000 | |
| $3.79 | -0.04 | -1.0% | $3.83 | $3.83 | $3.735 | 467,400 | |
| $3.83 | -0.06 | -1.5% | $3.86 | $3.945 | $3.83 | 287,200 | |
| $3.89 | -0.05 | -1.3% | $3.92 | $3.955 | $3.83 | 385,700 | |
| $3.94 | -0.03 | -0.8% | $3.93 | $3.96 | $3.89 | 203,000 | |
| $3.97 | +0.03 | +0.8% | $3.94 | $3.98 | $3.87 | 239,500 | |
| $3.94 | +0.04 | +1.0% | $3.92 | $4.00 | $3.855 | 335,400 | |
| $3.90 | +0.04 | +1.0% | $3.81 | $3.915 | $3.795 | 222,100 | |
| $3.86 | +0.04 | +1.0% | $3.79 | $3.88 | $3.72 | 506,500 | |
| $3.82 | -0.17 | -4.3% | $3.99 | $3.99 | $3.785 | 399,100 | |
| $3.99 | +0.08 | +2.0% | $3.93 | $4.04 | $3.90 | 256,800 | |
| $3.91 | -0.06 | -1.5% | $3.96 | $4.05 | $3.88 | 761,100 | |
| $3.97 | +0.10 | +2.6% | $3.87 | $3.99 | $3.86 | 272,500 | |
| $3.87 | +0.02 | +0.5% | $3.84 | $3.89 | $3.715 | 229,900 | |
| $3.85 | -0.05 | -1.3% | $3.91 | $3.95 | $3.81 | 238,200 | |
| $3.90 | -0.06 | -1.5% | $3.92 | $3.93 | $3.83 | 360,800 | |
| $3.96 | -0.02 | -0.5% | $4.06 | $4.115 | $3.95 | 359,600 | |
| $3.98 | 0.00 | 0.0% | $3.97 | $4.02 | $3.885 | 336,000 | |
| $3.98 | +0.01 | +0.3% | $3.96 | $4.01 | $3.93 | 268,100 | |
| $3.97 | +0.03 | +0.8% | $3.94 | $4.00 | $3.83 | 333,200 | |
| $3.94 | +0.05 | +1.3% | $3.91 | $3.995 | $3.85 | 309,900 | |
| $3.89 | -0.02 | -0.5% | $4.00 | $4.026 | $3.78 | 467,600 | |
| $3.91 | -0.20 | -4.9% | $4.00 | $4.03 | $3.85 | 618,100 | |
| $4.11 | -0.01 | -0.2% | $4.11 | $4.17 | $4.07 | 281,200 | |
| $4.12 | +0.02 | +0.5% | $4.13 | $4.175 | $4.005 | 340,300 | |
| $4.10 | +0.10 | +2.5% | $4.00 | $4.11 | $3.975 | 329,300 | |
| $4.00 | -0.01 | -0.2% | $4.05 | $4.125 | $3.97 | 480,700 | |
| $4.01 | +0.04 | +1.0% | $3.98 | $4.095 | $3.97 | 425,500 | |
| $3.97 | +0.05 | +1.3% | $3.94 | $3.99 | $3.87 | 241,600 | |
| $3.92 | -0.11 | -2.7% | $4.00 | $4.045 | $3.805 | 294,600 | |
| $4.03 | +0.22 | +5.8% | $3.80 | $4.045 | $3.771 | 273,100 |
- Ticker
- LS Exchange:A2P4JE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Latest earnings call · May 19, 2026
Protara Therapeutics (NASDAQ:TARA) Q1 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 33 slides
Calls
Replays
Protara Therapeutics (NASDAQ:TARA) Q1 2026 Earnings Call
Tue, May 19, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Oct 15, 2026
Closed $2.40 (-3.2%) on Oct 15, 2026
Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $3.83 (-1.5%) on Sep 9, 2026
Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
Aug 11, 2026
Closed $3.91 (-4.9%) on Aug 11, 2026
Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA
May 20, 2026
Closed $4.76 (+9.7%) on May 20, 2026
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
May 18, 2026
Closed $4.60 (-9.8%) on May 18, 2026
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
May 15, 2026
Closed $5.10 (-3.8%) on May 15, 2026
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
May 13, 2026
Closed $5.20 (+1.0%) on May 13, 2026
Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting
Apr 27, 2026
Closed $5.06 (+1.4%) on Apr 28, 2026
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Mar 10, 2026
Closed $5.71 (-0.7%) on Mar 10, 2026
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Feb 23, 2026
Closed $7.43 (+8.6%) on Feb 23, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 33 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 42 slides · May 19, 2026
Investor Presentation (February 2026)
Investor deck · 34 slides · Feb 24, 2026
ASCO Genitourinary (GU) Cancers Symposium 2026
Conference · 19 slides · Feb 24, 2026
Protara Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 115 in all · newest Oct 15, 2026 · oldest 2020
- Calls
- 1 call with a replay · 1 with a transcript · latest May 19, 2026
- Decks
- 18 decks · latest August 2026
Where Protara Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TARA · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2P4JE · This page | LS Exchange | Germany | EUR |
| gettex:1KPA | gettex | Germany | EUR |
| Lang & Schwarz:A2P4JE | Lang & Schwarz | Germany | EUR |
| BOATS:TARA | BOATS | United States | USD |
| Tradegate:1KPA | Tradegate | Germany | EUR |
| Dusseldorf:1KPA | Dusseldorf | Germany | EUR |
| Frankfurt:1KPA | Frankfurt | Germany | EUR |
| Hamburg:1KPA | Hamburg | Germany | EUR |
| Munich:1KPA | Munich | Germany | EUR |
| Stuttgart:1KPA | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Protara Therapeutics, Inc.